The Supreme Court granted certiorari to review whether a generic drugmaker that fully carves out a patented use from its ...
The Supreme Court on Jan. 16, 2026, agreed to decide a case about how generic companies can communicate to the market about their products, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results